Get notified of page updates

Genetic testing benefits for people diagnosed with , ovarian or primary peritoneal cancer 

For women who have been diagnosed with , ovarian or primary peritoneal cancer, genetic testing may provide the following information and benefit:

  • Your test results may make you eligible for treatment with a  (e.g., PARP inhibitors) or a clinical trial.
  • If you test positive for an in  or , you may benefit from treatment with an  agent
  • The test can help you understand your risk for a new cancer diagnosis and options for managing your risk.
  • Your results can help your relatives understand their risk for cancer and take actions to stay healthy.
Last updated February 02, 2022